HomeCompareAQNU vs PFE

AQNU vs PFE: Dividend Comparison 2026

AQNU yields 20.04% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $24.9K in total portfolio value· pulled ahead in Year 9
10 years
AQNU
AQNU
● Live price
20.04%
Share price
$19.34
Annual div
$3.88
5Y div CAGR
-42.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.6K
Annual income
$9.91
Full AQNU calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — AQNU vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAQNUPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AQNU + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AQNU pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AQNU
Annual income on $10K today (after 15% tax)
$1,703.12/yr
After 10yr DRIP, annual income (after tax)
$8.42/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,311.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AQNU + PFE for your $10,000?

AQNU: 50%PFE: 50%
100% PFE50/50100% AQNU
Portfolio after 10yr
$37.1K
Annual income
$13,134.31/yr
Blended yield
35.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

AQNU
Analyst Ratings
2
Buy
6
Hold
1
Sell
Consensus: Hold
Altman Z
0.7
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AQNU buys
0
PFE buys
0
No recent congressional trades found for AQNU or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAQNUPFE
Forward yield20.04%6.13%
Annual dividend / share$3.88$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-42.5%13.2%
Portfolio after 10y$24.6K$49.6K
Annual income after 10y$9.91$26,258.71
Total dividends collected$3.0K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold

Year-by-year: AQNU vs PFE ($10,000, DRIP)

YearAQNU PortfolioAQNU Income/yrPFE PortfolioPFE Income/yrGap
1$11,852$1,152.11$9,153$693.39+$2.7KAQNU
2$13,416$733.79$8,593$849.25+$4.8KAQNU
3$14,801$446.35$8,336$1,066.78+$6.5KAQNU
4$16,102$264.63$8,437$1,384.80+$7.7KAQNU
5$17,384$154.70$9,013$1,875.40+$8.4KAQNU
6$18,690$89.75$10,306$2,680.72+$8.4KAQNU
7$20,050$51.86$12,820$4,101.38+$7.2KAQNU
8$21,484$29.90$17,673$6,826.70+$3.8KAQNU
9← crossover$23,005$17.21$27,543$12,591.86$4.5KPFE
10$24,625$9.91$49,560$26,258.71$24.9KPFE

AQNU vs PFE: Complete Analysis 2026

AQNUStock

Algonquin Power & Utilities Corp., through its subsidiaries, owns and operates a portfolio of regulated and non-regulated generation, distribution, and transmission utility assets. The company operates through two segments, Regulated Services Group and Renewable Energy Group. The Regulated Services Group segment operates a portfolio of rate-regulated utilities located in the United States, Canada, Chile, and Bermuda. Its utilities provide distribution services to approximately 1,093,000 customer connections in the electric, natural gas, and water and wastewater sectors The Renewable Energy Group segment generates and sells electrical energy, capacity, ancillary products, and renewable attributes produced by its portfolio of renewable and clean power generation facilities primarily in the United States and Canada. It owns and operates hydroelectric, wind, solar, and thermal facilities; and owns and operates a portfolio of clean energy and water infrastructure assets. The company was incorporated in 1988 and is headquartered in Oakville, Canada.

Full AQNU Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this AQNU vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AQNU vs SCHDAQNU vs JEPIAQNU vs OAQNU vs KOAQNU vs MAINAQNU vs JNJAQNU vs MRKAQNU vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.